4-iodophenyl-9-methylpentadecanoic acid and Hibernation, Myocardial

4-iodophenyl-9-methylpentadecanoic acid has been researched along with Hibernation, Myocardial in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Horikoshi, M; Lee, JD; Nakano, A; Okura, K; Shimizu, H; Takahashi, N; Tsuchida, T; Ueda, T; Yonekura, Y	1

Trials

1 trial(s) available for 4-iodophenyl-9-methylpentadecanoic acid and Hibernation, Myocardial

Article	Year
Reversible defect of 123I-15-(p-iodophenyl)-9-(R,S)-methylpentadecanoic acid indicates residual viability within infarct-related area. Annals of nuclear medicine, 2002, Volume: 16, Issue:3 Topics: Aged; Fatty Acids; Female; Fluorodeoxyglucose F18; Heart; Humans; Iodobenzenes; Male; Middle Aged; Myocardial Infarction; Myocardial Stunning; Myocardium; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Reference Values	2002

Article

Year

Reversible defect of 123I-15-(p-iodophenyl)-9-(R,S)-methylpentadecanoic acid indicates residual viability within infarct-related area.

Annals of nuclear medicine, 2002, Volume: 16, Issue:3

Topics: Aged; Fatty Acids; Female; Fluorodeoxyglucose F18; Heart; Humans; Iodobenzenes; Male; Middle Aged; Myocardial Infarction; Myocardial Stunning; Myocardium; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Reference Values

2002